In vitro-transcribed mRNAs have been proven efficient in various therapeutic applications. However, manufacturing them poses challenges due in part to complexity of the molecules as well as the ...
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...
A graduate student from the Massachusetts Institute of Technology (MIT) is poised to commercialize a new technology for improving the cost-effectiveness of mRNA manufacture. Nathan Stover is working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback